BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9080116)

  • 1. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.
    Anderegg B; Horstmann M; Kabisch H
    Cancer Gene Ther; 1997; 4(2):84-90. PubMed ID: 9080116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.
    Breit TM; Wolvers-Tettero IL; van Dongen JJ
    Oncogene; 1994 Jul; 9(7):1847-53. PubMed ID: 8208530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
    Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
    Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
    Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
    Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
    Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
    Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.
    Smith MR; Abubakr Y; Mohammad R; Xie T; Hamdan M; al-Katib A
    Cancer Gene Ther; 1995 Sep; 2(3):207-12. PubMed ID: 8528964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
    Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
    Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin immunoselection defines a TAL-1 target gene.
    Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
    EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
    Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
    Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
    Curry JD; Smith MT
    Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TAL-1 proteins in human tissues.
    Pulford K; Lecointe N; Leroy-Viard K; Jones M; Mathieu-Mahul D; Mason DY
    Blood; 1995 Feb; 85(3):675-84. PubMed ID: 7833471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pufferfish SLP-1 gene, a new member of the SCL/TAL-1 family of transcription factors.
    Göttgens B; Gilbert JG; Barton LM; Aparicio S; Hawker K; Mistry S; Vaudin M; King A; Bentley D; Elgar G; Green AR
    Genomics; 1998 Feb; 48(1):52-62. PubMed ID: 9503016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
    Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
    J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.
    Baśkiewicz-Masiuk M; Walczak M; Grzegrzółka R; Rogowska D; Machaliński B
    Arch Dermatol Res; 2006 Apr; 297(10):450-8. PubMed ID: 16502315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
    Cheng JT; Hsu HL; Hwang LY; Baer R
    Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides.
    Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1995; 15(1):37-43. PubMed ID: 7733638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y; Cherton-Horvat G; Dragowska V; Baird S; Korneluk RG; Durkin JP; Mayer LD; LaCasse EC
    Clin Cancer Res; 2003 Jul; 9(7):2826-36. PubMed ID: 12855663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.